CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 261 enrolled
Drug / intervention
Doxycycline +1 moredrug
Likely dose
Doxycycline 100 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01756833
NCT01756833Phase 2Completed
CompareCT.gov

Non-Invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial (N-TA^3CT)

University of Maryland, Baltimore·interventional·Posted Dec 28, 2012·Updated Nov 26, 2021

In Brief

A Phase 2 clinical trial evaluating Doxycycline and Placebo for Aneurysm. Completed, enrolled 261 participants across 22 sites.

Detailed Summary

The primary aim of this study is to determine if doxycycline (100 mg bid) will inhibit (by at least 40%) the increase in greatest transverse diameter of small abdominal aortic aneurysms (3.5-5.0 cm in men, 3.5-4.5 cm in women) over a 24-month period of observation in comparison to a placebo-treated control group.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAneurysm
CountriesUnited States
CollaboratorsNational Institute on Aging (NIA)

Timeline

Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedDec 28, 2012
Enrollment StartMay 1, 2013
Primary CompletionJul 23, 2019
TodayJul 2, 2026
Enrollment to primary: 6.2 yearsPosted 13.5 years ago

Interventions

Doxycyclinedrug

100 mg po bid

Placebodrug

capsule identical to the doxycycline capsule